Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nitric Oxide ; 71: 21-26, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-29031734

RESUMEN

Shear stress or vasocontriction causes endothelial nitric oxide (NO) release resulting in the regulation of vascular smooth muscle tone in small resistance arteries. Generation of NO is inhibited by nitric oxide synthase (NOS) inhibitors. In this study, we investigated the effect of residual NO, released even in the presence of NOS inhibitors, on the membrane depolarization and phenylephrine-induced contractions of smooth muscle. For this purpose, we used hydroxocobalamin (HC), an NO scavenger, in the presence of NOS inhibitiors, Nω-nitro- L-arginine (L-NA) or Nω-nitro-L-arginine methyl ester (L-NAME) in mesenteric arteries isolated from rats. Phenylephrine (0,01-10 µM), an α1-adrenoceptor agonist, led to depolarisation and concentration-dependent contraction in mesenteric arteries. The depolarisation and contractile responses were augmented by L-NA or L-NAME. Hydroxocobalamine (HC) or carboxy-PTIO (c-PTIO) also caused to further increase the membrane depolarization and contractions induced by phenylephrine in the presence of NOS inhibitors. Chemical removal of endothelium by saponin, tyrosin kinase inhibitor erbstatin A, but not calmodulin inhibitor calmidazolium inhibited the additional membrane depolarisation and contractile responses induced by L-NA or L-NAME and L-NA or L-NAME plus HC. These findings show that residual NO modulates the contractile responses in isolated rat mesenteric arteries by exerting a tonic inhibitor effect on the depolarization and vasoconstriction induced by phenylephrine.


Asunto(s)
Potenciales de la Membrana/efectos de los fármacos , Arterias Mesentéricas/metabolismo , Contracción Muscular/efectos de los fármacos , Óxido Nítrico/metabolismo , Agonistas de Receptores Adrenérgicos alfa 1/farmacología , Animales , Benzoatos/farmacología , Depuradores de Radicales Libres/farmacología , Hidroxocobalamina/farmacología , Imidazoles/farmacología , Masculino , Arterias Mesentéricas/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Nitroarginina/farmacología , Fenilefrina/farmacología , Inhibidores de Proteínas Quinasas/farmacología , Ratas Wistar
2.
J Basic Clin Physiol Pharmacol ; 24(2): 143-50, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23412870

RESUMEN

BACKGROUND: The aim of this study was to investigate whether thiols are involved in the nitrergic neurotransmission in mouse duodenum. METHODS: The effects of thiol-modulating agents, ethacrynic acid (100 µM), a non-specific sulfhydryl alkylator, and diamide (100 µM), an alkylating agent that oxidizes protein sulfhydryl groups and depletes intracellular glutathione, on relaxations to nitrergic stimulation (electrical field stimulation, EFS;10 Hz, 25 V, 1 ms, 15 s-train), S-nitrosoglutathione (GSNO; 5 µM), S-nitroso-acetylpenicillamine (SNAP; 5 µM), and S-nitrosocysteine (CysNO; 10 µM) were investigated. Moreover, the effects of buthionine sulfoximine (100 µM), an inhibitor of γ-glutamylcysteine synthetase, and sulfobromophthalein (100 µM), an inhibitor of glutathione-S-transferase, were studied on relaxant responses to EFS and S-nitrosothiols in mouse duodenum. RESULTS: Exogenous free thiol, glutathione (GSH, 100 µM) did not influence relaxation to EFS, GSNO, SNAP, and CysNO. Ethacrynic acid and diamide significantly decreased relaxation of duodenum to EFS, GSNO, SNAP, and CysNO. This inhibition was prevented by addition of GSH. Buthionine sulfoximine and sulfobromophthalein significantly decreased relaxation to EFS and GSNO but did not influence relaxation to SNAP and CysNO. The inhibitory effect of buthionine sulfoximine and sulfobromophthalein on the relaxant response to EFS and GSNO was prevented by addition of GSH. CONCLUSIONS: These results suggest that relaxation to nitrergic stimulation is thiol-dependent, and nitrosothiols, possibly S-nitrosoglutathione may play a role, as an intermediate compound in nitrergic neurotransmission in mouse duodenum.


Asunto(s)
Duodeno/efectos de los fármacos , Relajación Muscular/efectos de los fármacos , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico/fisiología , S-Nitrosotioles/farmacología , Reactivos de Sulfhidrilo/farmacología , Análisis de Varianza , Animales , Butionina Sulfoximina/farmacología , Cisteína/análogos & derivados , Cisteína/farmacología , Diuréticos/farmacología , Relación Dosis-Respuesta a Droga , Ácido Etacrínico/farmacología , Femenino , Glutamato-Cisteína Ligasa/antagonistas & inhibidores , Glutatión Transferasa/antagonistas & inhibidores , Masculino , Ratones , S-Nitroso-N-Acetilpenicilamina/farmacología , S-Nitrosoglutatión/farmacología , Sulfobromoftaleína/farmacología , Transmisión Sináptica/efectos de los fármacos , Vasodilatadores/farmacología
3.
Acta Pharmacol Sin ; 29(6): 687-97, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18501115

RESUMEN

AIM: The aim of this study was to investigate whether superoxide dismutase (SOD) enzymes and ascorbate play a role in the protection of the nitrergic relaxation against superoxide anion inhibition in the mouse duodenum. METHODS: The effects of exogenous SOD, N,No-bis(salicylidene) ethylenediamine chloride (EUK-8; a synthetic cell-permeable mimetic of the manganese SOD [Mn-SOD] and ascorbate on relaxant responses induced by nitrergic nerve stimulation), exogenous nitric oxide (NO), and nitroglycerin were investigated in isolated mouse duodenum tissues. RESULTS: Diethyldithiocarbamate (DETCA) inhibited the relaxation to exogenous NO and nitroglycerin, but not relaxation to electrical field stimulation (EFS). SOD and ascorbate partially prevented the inhibitory effect of DETCA on relaxation to NO, abut not to nitroglycerin. The DETCA-induced inhibition on nitroglycerin was prevented by EUK-8. Hemoglobin, 2- (4-carboxyphenyl)-4,4,5,5-tetramethylimidazolinel-oxyl-3-oxide, and hydroxocobalamin inhibited the relaxation to NO, but not to EFS and nitroglycerin in the presence of DETCA. Pyrogallol and hydroquinone inhibited the relaxation to NO, but not to EFS and nitroglycerin. This inhibition was prevented by exogenous SOD and ascorbate, but was not prevented by EUK-8. Pyrogallol and hydroquinone did not inhibit the EFS-induced relaxation in the presence of DETCA. Duroquinone and 6-anilino-5.8-quinolinedione inhibited the relaxation to EFS, NO, and nitroglycerin, and this inhibition was prevented by EUK-8. CONCLUSION: These results suggest that the nitrergic neurotransmission in the mouse duodenum is protected by endogenous tissue antioxidants against superoxide anions, and Mn SOD, in addition to copper/zinc SOD, can protect NO from attack from superoxide anion generators intracellularly. Also, the possibility that the endogenous neurotransmitter may not be the free NO but a NO-containing or NO-generating molecule in the mouse duodenum remains open.


Asunto(s)
Ácido Ascórbico/farmacología , Duodeno/fisiología , Depuradores de Radicales Libres/farmacología , Músculo Liso/fisiología , Óxido Nítrico/fisiología , Oxidantes/metabolismo , Superóxido Dismutasa/fisiología , Superóxidos/metabolismo , Animales , Antioxidantes/farmacología , Duodeno/efectos de los fármacos , Estradiol/análogos & derivados , Estradiol/farmacología , Etilenodiaminas/farmacología , Femenino , Técnicas In Vitro , Masculino , Ratones , Relajación Muscular/efectos de los fármacos , Relajación Muscular/fisiología , Músculo Liso/efectos de los fármacos , Compuestos Organometálicos/farmacología
4.
Tohoku J Exp Med ; 213(1): 89-98, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17785957

RESUMEN

Urocortin, a member of corticotropin releasing factor (CRF) peptide family, has positive chronotropic and inotropic effects on heart and also shows a vasodilatory effect. However, the mechanism underlying its vasodilatory effect has yet to be elucidated. Endothelium-dependent relaxation of resistance arteries is mainly achieved by activation of K+ channels. Therefore, we investigated possible role of K+ channels and hyperpolarization for the vasodilatory effect of urocortin using the isolated perfused rat mesenteric arteries. Urocortin (0.2 nM) produced a slow-onset decrease in the perfusion pressure of the mesenteric vascular bed, which was elevated by an alpha1-adrenoceptor agonist, phenylephrine (2-4 microM). Urocortin also hyperpolarized the main mesenteric artery. Removal of endothelium with saponin treatment considerably inhibited the relaxation and hyperpolarization induced by urocortin. In contrast, the hyperpolarization was not significantly changed by cyclooxygenase inhibitor, indomethacin (1 microM) and/or nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine (100 microM). Urocortin-induced relaxation was not affected by the combination of a guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 microM), indomethacin and N(omega)-nitro-L-arginine. However, the relaxation and hyperpolarization were abolished by high extracellular potassium concentration (40 mM) or by a large conductance Ca(2+)-activated K+ channel blocker, charybdotoxin (1 nM). Glibenclamide (1 microM), an ATP-dependent K+ channel inhibitor, did not affect the relaxation and hyperpolarization. These results suggest that urocortin causes endothelium-dependent relaxation and hyperpolarization of rat mesenteric arteries, probably through the activation of charybdotoxin sensitive Ca2+-activated K+ channels. These findings also indicate an essential role of the endothelium for the urocortin-elicited vascular relaxation and hyperpolarization.


Asunto(s)
Hormona Liberadora de Corticotropina/farmacología , Endotelio Vascular/fisiología , Arteria Mesentérica Superior/fisiología , Canales de Potasio Calcio-Activados/fisiología , Vasodilatación/efectos de los fármacos , Acetilcolina/farmacología , Animales , Electrofisiología , Endotelio Vascular/efectos de los fármacos , Masculino , Arteria Mesentérica Superior/efectos de los fármacos , Canales de Potasio Calcio-Activados/efectos de los fármacos , Ratas , Ratas Wistar , Urocortinas
5.
Pharmacology ; 71(3): 128-34, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15161994

RESUMEN

We investigated whether bacterial lipopolysaccharide treatment causes any neuronal and vascular hyporeactivity in mouse cavernous tissue and also whether melatonin has any restorative effect on this possible neuronal and vascular hyporesponsiveness. Lipopolysaccharide treatment attenuated contractions in response to phenylephrine. Treatment with the inducible nitric oxide synthase inhibitor aminoguanidine or melatonin restored the hypocontractility of the cavernous smooth muscle to phenylephrine. Relaxant responses of corpus cavernosum precontracted by phenylephrine to acetylcholine or electrical field stimulation were significantly impaired in mice treated with bacterial lipopolysaccharide. Treatment with aminoguanidine or melatonin could prevent the impairment of the neuronal and endothelial relaxations. There was no significant difference between control and lipopolysaccharide-treated groups in the contractile response to high-dose KCl and in the relaxant response to papaverine. In conclusion, bacterial lipopolysaccharide treatment caused a neuronal and endothelial dysfunction in the mouse corpus cavernosum. A possible increased oxidative activity in the cavernous tissue may be a major reason for the impairment of relaxant responses and hypocontracility of tissue. The restorative effects of melatonin on this hyporeactivity may depend on its antioxidant properties and partly on its inhibitory action on the inducible nitric oxide synthase production.


Asunto(s)
Lipopolisacáridos/toxicidad , Melatonina/farmacología , Pene/efectos de los fármacos , Acetilcolina/farmacología , Animales , Estimulación Eléctrica , Endotelio/efectos de los fármacos , Endotelio/fisiología , Escherichia coli , Técnicas In Vitro , Masculino , Ratones , Relajación Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Papaverina/farmacología , Pene/irrigación sanguínea , Pene/inervación , Vasodilatadores/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA